Atlas Trials

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Clinical trial NCT04616248 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04616248
Sponsor
University of Southern California
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8Unresectable Breast CarcinomaMetastatic MelanomaUnresectable MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaSoft Tissue SarcomaBone SarcomaSarcoma,Soft TissueSarcoma of Bone
Start date
2023-01-09
Primary completion
2027-01-09
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.